CD28 and central nervous system cancer: To investigate whether the metabolic regulators prevent decreases in OXPHOS, we chronically stimulated CAR-T cells with SB28 mEGFRvIII gliomas or anti-CD3/anti-CD28 beads under hypoxia (Figure 3C).